PTCA药物涂层球囊(DCB)导管市场:开发平台报告(开发阶段，市场区隔，地区·国家，法规途径，主要企业)，2024年最新版

药物涂层球囊（DCB）导管是一种抗再狭窄药物涂层PTCA球囊导管，旨在预防冠状动脉再狭窄。 DCB 导管提供快速、短期、均匀和局部的药物输送。 DCB 导管可保留血管解剖结构，促进血管癒合，并减少长期双重抗血小板治疗的需要，且不会留下金属

本报告提供PTCA药物涂层球囊(DCB)导管市场相关调查，提供产品概要与正在开发的开发中产品趋势，各种处于开发阶段的产品的比较分析和进行中的临床试验相关资讯，参与企业的最近的趋势等资讯。

目录

第1章 目录

第2章 简介

• PTCA药物涂层球囊(DCB)导管概要

第3章 开发中的产品

• PTCA药物涂层球囊(DCB)导管 - 各开发阶段平台产品
• PTCA药物涂层球囊(DCB)导管 - 各地区开发中产品
• PTCA药物涂层球囊(DCB)导管 - 各法规途径开发中产品
• PTCA药物涂层球囊(DCB)导管 - 估计核准日开发中产品
• PTCA药物涂层球囊(DCB)导管 - 进行中的临床试验

第4章 PTCA药物涂层球囊(DCB)导管- 各公司正在开发的开发中产品

• PTCA药物涂层球囊(DCB)导管企业- 各开发阶段的开发中产品
• PTCA药物涂层球囊(DCB)导管- 各开发阶段的开发中产品

第5章 PTCA药物涂层球囊(DCB)导管的企业和产品概要

• Aachen Resonance GmbH
• Acotec Scientific Co Ltd
• Advanced NanoTherapies Inc
• B. Braun Interventional Systems Inc
• Boston Scientific Corp
• Caliber Therapeutics, Inc.
• Chansu Vascular Technologies LLC
• Concept Medical Inc
• Cordis US Corp
• Dongguan TT Medical Inc
• Innova Vascular Inc
• Jiwei Medical System Ltd
• Lepu Medical Technology(北京)Co Ltd
• Lifetech Scientific (Shenzhen) Co Ltd
• Medtronic Plc
• MicroPort Scientific Corp
• OrbusNeich
• Orchestra BioMed Inc
• QT Vascular Ltd
• Rontis Hellas SA
• Shanghai MicroPort Medical Group Co Ltd
• Shanghai XinZhi Medical Technology Co Ltd
• Shenzhen Salubris Pharmaceuticals Co Ltd
• Spectranetics Corp
• Vascular Nanotransfer Technologies

第6章 PTCA药物涂层球囊(DCB)导管- 最近的开发

第7章 附录

• 调查手法
• 关于GlobalData
• 咨询方式
• 免责声明

GlobalData's Medical Devices sector report, "PTCA Drug Coated Balloon (DCB) Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the PTCA Drug Coated Balloon (DCB) Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. DCB Catheters provide fast, short-term, homogenous, local drug delivery. DCB catheters preserve the anatomy of the vessel, promote enhanced vessel healing, and reduce the need for prolonged dual anti-platelet therapy without leaving any metal behind.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the PTCA Drug Coated Balloon (DCB) Catheters under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of PTCA Drug Coated Balloon (DCB) Catheters and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of PTCA Drug Coated Balloon (DCB) Catheters under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 PTCA Drug Coated Balloon (DCB) Catheters Overview

3 Products under Development

• 3.1 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• 3.2 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• 3.3 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• 3.4 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• 3.5 PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials

4 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products under Development by Companies

• 4.1 PTCA Drug Coated Balloon (DCB) Catheters Companies - Pipeline Products by Stage of Development
• 4.2 PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development

5 PTCA Drug Coated Balloon (DCB) Catheters Companies and Product Overview

• 5.1 Aachen Resonance GmbH Company Overview
  • 5.1.1 Aachen Resonance GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Acotec Scientific Co Ltd Company Overview
  • 5.2.1 Acotec Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Advanced NanoTherapies Inc Company Overview
  • 5.3.1 Advanced NanoTherapies Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 B. Braun Interventional Systems Inc Company Overview
  • 5.4.1 B. Braun Interventional Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Boston Scientific Corp Company Overview
  • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Caliber Therapeutics, Inc. Company Overview
  • 5.6.1 Caliber Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Chansu Vascular Technologies LLC Company Overview
  • 5.7.1 Chansu Vascular Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 Concept Medical Inc Company Overview
  • 5.8.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Cordis US Corp Company Overview
  • 5.9.1 Cordis US Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Dongguan TT Medical Inc Company Overview
  • 5.10.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Innova Vascular Inc Company Overview
  • 5.11.1 Innova Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 Jiwei Medical System Ltd Company Overview
  • 5.12.1 Jiwei Medical System Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Lepu Medical Technology (Beijing) Co Ltd Company Overview
  • 5.13.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  • 5.14.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 Medtronic Plc Company Overview
  • 5.15.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 MicroPort Scientific Corp Company Overview
  • 5.16.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 OrbusNeich Company Overview
  • 5.17.1 OrbusNeich Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Orchestra BioMed Inc Company Overview
  • 5.18.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 QT Vascular Ltd Company Overview
  • 5.19.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Rontis Hellas SA Company Overview
  • 5.20.1 Rontis Hellas SA Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 Shanghai MicroPort Medical Group Co Ltd Company Overview
  • 5.21.1 Shanghai MicroPort Medical Group Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Shanghai XinZhi Medical Technology Co Ltd Company Overview
  • 5.22.1 Shanghai XinZhi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
  • 5.23.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Spectranetics Corp Company Overview
  • 5.24.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Vascular Nanotransfer Technologies Company Overview
  • 5.25.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

6 PTCA Drug Coated Balloon (DCB) Catheters- Recent Developments

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials
• PTCA Drug Coated Balloon (DCB) Catheters Companies - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• Glossary

List of Figures

• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Stage of Development
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Territory
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Regulatory Path
• PTCA Drug Coated Balloon (DCB) Catheters - Pipeline Products by Estimated Approval Date
• PTCA Drug Coated Balloon (DCB) Catheters - Ongoing Clinical Trials